NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute has awarded a consortium of institutions $14.4 million to research better methods of predicting which hypertrophic cardiomyopathy patients are at the highest risk of heart failure or sudden death.

The University of Virginia School of Medicine and the University of Oxford in the UK, will direct the five-year study which will follow 2,750 patients for up to five years. The study will be conducted at 35 to 40 sites in the US, Canada, and Europe, including the UK, Italy and Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.